Professor of Ophthalmology (University of Sydney/Westmead Millennium Institute) and Director of Ophthalmology (Sydney West Local Health Network), University of Sydney and Affiliated Institutes, Australia
Paul Mitchell is Professor of Ophthalmology at the University of Sydney (Westmead Millennium Institute), based at Westmead Hospital in Sydney, Australia. He works as a medical retina specialist, is Director of Ophthalmology for the Sydney West Local Health Network, and heads a retina practice (Sydney West Retina). His clinical focus is the management of AMD and diabetic retinopathy (particularly using anti-VEGF therapy) and other vascular retinopathies, and in evaluating ocular effects of systemic diseases.
Professor Mitchell has co-authored 900 papers in peer-reviewed journals, plus 75 books, chapters or letters, and currently has ~37,000 citations to his work. He has been the recipient of many awards and prizes, and served as an ARVO Trustee and as ARVO Vice President. He was the principal investigator on the Blue Mountains Eye Study and other major epidemiological studies of eye disease and vision impairment.
Professor Mitchell has a strong interest in the development, evaluation and application of evidence-based treatment guidelines in ophthalmology, particularly in new therapies for AMD, diabetic retinopathy / macular edema and RVO, and for other retinal diseases. He was a senior investigator, and enrolled patients in many pivotal randomized clinical trials in medical retina, including many recent studies.